Dilip Sanghvi led Sun Pharmaceutical Industries is acquiring GlaxoSmithKline's Australian opiates business. The financial details of the deal remain undisclosed. The buy consists of two manufacturing sites, one each in Latrobe (Tasmania) and Port ... Deal Curry, 2 days ago
MUMBAI: Dilip Shantilal Shanghvi, the world's richest pharma tycoon and Sun Pharma managing director, is increasingly expanding his business empire into new and diverse areas, making big investments in areas such as renewable energy and payment ...Economic Times, 2 weeks ago
Sun Pharma dismisses buzz; Suzlon up over three per cent Digbijay Mishra & Shreya Jai | New Delhi February 3, 2015 Last Updated at 00:49 IST Shares of Suzlon rose over three per cent today on speculation that Dilip Shanghvi of Sun Pharmaceuticals ...Business Standard India, 1 month ago
Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'
A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive ...Morningstar.com, 2 days ago The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts Pharmacy Choice, 1 week ago The Generic Drugs Market: 2015 2030 - Opportunities, Challenges, Strategies & Forecasts Research and Markets, 2 weeks ago
The boards of India's two leading pharmaceutical companies, Sun Pharmaceuticals and RanbaxyLaboratories, announced their merger in April 2014. In what is touted to be one of the biggest M&A deals in the Indian market, estimated at US$4 billion, Sun ...Investopedia, 6 days ago
Summit Therapeutics plc ('Summit' or the 'Company') SUMMIT APPOINTS MR DAVID WURZER AS NON-EXECUTIVE DIRECTOR Oxford, UK, 23 February 2015 - Summit Therapeutics plc (AIM: SUMM), the drug discovery and development company advancing therapies ...EuroInvestor, 1 week ago Summit Therapeutics plc Summit Therapeutics Appoints Mr David Wurzer As A Non-Executive Director ADVFN UK, 1 week ago IP : Summit Therapeutics plc - Summit Therapeutics Appoints Mr David Wurzer 4 Traders, 1 week ago Summit Therapeutics plc - Summit Therapeutics Appoints Mr David Wurzer Noodls, 1 week ago
More from: , Reuters...and 2 other sources
The second richest person in India, the seventh richest self-made billionaire in Asia and the richest person in the healthcare industry with a net worth of approximately US$18 billion -- all these adjectives can be used to describe Mr. Dilip ...Investopedia, 1 month ago
on your WebpageAdd Widget >Get your members hooked!